Shares of Verici Dx plc (LON:VRCI – Get Free Report) shot up 18.4% on Wednesday . The company traded as high as GBX 3.72 ($0.05) and last traded at GBX 3.70 ($0.05). 902,539 shares were traded during mid-day trading, an increase of 23% from the average session volume of 735,333 shares. The stock had previously closed at GBX 3.13 ($0.04).
Verici Dx Price Performance
The company has a market cap of £8.97 million, a PE ratio of -184.95 and a beta of 1.59. The firm’s 50-day moving average is GBX 3.60 and its 200-day moving average is GBX 4.82. The company has a quick ratio of 8.49, a current ratio of 4.54 and a debt-to-equity ratio of 4.65.
About Verici Dx
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
Recommended Stories
- Five stocks we like better than Verici Dx
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- Following Congress Stock Trades
- Inflation Persists, But So Do Stock Opportunities: Rally On
- Using the MarketBeat Dividend Tax Calculator
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
